Xingsheng Hu

机构：Capital Medical University, Yunnan University, Chinese Academy of Medical Sciences & Peking Union Medical College, Shanghai Medical Information Center, Second People's Hospital of Yunnan Province, Ministry of Education, Beijing Chest Hospital, Affiliated Hospital of North Sichuan Medical College, Institute of Hematology & Blood Diseases Hospital, Tongji Hospital, Huazhong University of Science and Technology · ORCID：0000-0002-6652-2384

发表论文 164 篇 · 总被引 1859 次 · h-index 24

代表论文

• Mechanism exploration and model construction for small cell transformation in EGFR-mutant lung adenocarcinomas (2024 · Signal Transduction and Targeted Therapy · 被引 24)
• Ficonalkib (SY-3505) in Advanced ALK-Positive NSCLC: A Multicenter, Open-Label, Single-Arm, Phase 1/2 Study (2024 · Journal of Thoracic Oncology · 被引 7)
• 1208MO A randomized phase III trial of site-specific therapy guided by the 90-gene expression assay versus empiric chemotherapy in patients with cancer of unknown primary (2023 · Annals of Oncology · 被引 6)
• Electron‐Trap Induced “Hot” Microenvironment Boosting Photocatalytic Nitrogen Fixation (2025 · Angewandte Chemie International Edition · 被引 5)
• Clinical, immune cell, and genetic features predicting survival and long-term response to first-line chemo-immunotherapy treatment for non-small cell lung cancer (2025 · Cancer Immunology Immunotherapy · 被引 4)
• Proteomic profiling reveals the significance of lipid metabolism in small cell lung cancer recurrence and metastasis (2024 · Journal of Translational Medicine · 被引 4)